Description: Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
Home Page: filament.health
2900 – 550 Burrard Street
Vancouver,
BC
V6C 0A3
Canada
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Benjamin Lightburn | Co-Founder, CEO & Director |
| Mr. Tom Kineshanko | Co-Founder |
| Mr. Warren Duncan | Chief Financial Officer |
| Mr. Jon Conlin | Corp. Sec. & Director |
| Ms. Lisa Ranken | Chief Operating Officer |
| Mr. Ryan Moss | Chief Science Officer |
| Ms. Anna Cordon | Director of Communications |
| Mr. Jeff Fellows | Head of Regulatory |
Exchange: NEO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8293 |
| Price-to-Sales TTM: | 71.9585 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 11 |